The Influence of Polymeric Versus Oligomeric Enteral Feeding on Tolerance and Nutritional Status in Paediatric Intensive Care Pilot
Launched by BRNO UNIVERSITY HOSPITAL · Feb 28, 2022
Trial Information
Current as of May 29, 2025
Unknown status
Keywords
ClinConnect Summary
This clinical trial is looking at how two different types of enteral feeding—polymeric and oligomeric—affect how well young patients in the Pediatric Intensive Care Unit (PICU) can tolerate their nutritional support. Enteral feeding is a way to provide nutrition directly into the stomach or intestines when patients cannot eat by mouth. The researchers want to find out if one type of formula helps patients feel better and receive the nutrition they need without complications, which is especially important for critically ill children.
To be eligible for this trial, patients must be in the PICU and require enteral feeding. However, there are some important reasons that might prevent someone from joining, such as if they have certain medical conditions or recent surgeries. If a patient participates, they can expect to follow a specific feeding protocol while being monitored closely by healthcare professionals. This study aims to improve how enteral feeding is managed in young patients, which could lead to better health outcomes in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • PICU patients indicated for nutritional support by enteral feeding (gastric or jejunal)
- Exclusion Criteria:
- • Enteral feeding contraindicated
- • Persistent haemodynamic instability
- • Informed consent not signed
- • Acute pancreatitis
- • Recent upper gastrointestinal surgery
- • Gut perforation
- • Ileus
About Brno University Hospital
Brno University Hospital is a leading clinical research institution based in the Czech Republic, dedicated to advancing medical knowledge and patient care through innovative research and clinical trials. With a strong emphasis on multidisciplinary collaboration, the hospital harnesses the expertise of its diverse medical staff and state-of-the-art facilities to conduct high-quality studies across various therapeutic areas. Committed to ethical standards and patient safety, Brno University Hospital plays a pivotal role in translating scientific discoveries into effective treatments, contributing significantly to the advancement of healthcare both locally and internationally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Brno, South Moravian Region, Czechia
Patients applied
Trial Officials
Petr Stourac, prof. MD., Ph.D., MBA
Study Chair
Department of paediatric anaesthesiology and intensive care medicine
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials